T-Lymphocytes
"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
| Descriptor ID |
D013601
|
| MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
| Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 12 | 8 | 20 | | 1997 | 20 | 6 | 26 | | 1998 | 20 | 7 | 27 | | 1999 | 19 | 7 | 26 | | 2000 | 22 | 5 | 27 | | 2001 | 23 | 10 | 33 | | 2002 | 21 | 15 | 36 | | 2003 | 20 | 10 | 30 | | 2004 | 23 | 15 | 38 | | 2005 | 28 | 8 | 36 | | 2006 | 21 | 13 | 34 | | 2007 | 17 | 9 | 26 | | 2008 | 17 | 16 | 33 | | 2009 | 23 | 14 | 37 | | 2010 | 15 | 15 | 30 | | 2011 | 11 | 20 | 31 | | 2012 | 15 | 12 | 27 | | 2013 | 28 | 14 | 42 | | 2014 | 13 | 13 | 26 | | 2015 | 18 | 11 | 29 | | 2016 | 13 | 6 | 19 | | 2017 | 19 | 14 | 33 | | 2018 | 21 | 27 | 48 | | 2019 | 24 | 24 | 48 | | 2020 | 26 | 25 | 51 | | 2021 | 22 | 27 | 49 | | 2022 | 8 | 18 | 26 | | 2023 | 3 | 28 | 31 | | 2024 | 13 | 27 | 40 | | 2025 | 28 | 5 | 33 | | 2026 | 18 | 10 | 28 |
To return to the timeline, click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Bock M, Benz E, Blanchette E, Goebel J, Wedermyer G, Roark C, Wachs M, Adams M, Sundaram S, Chandran M. Excellent Long-Term Outcome in a Staged, Simultaneous Liver-Kidney Transplantation of a Highly Sensitized Pediatric Patient With B and T Cell Positive Crossmatch. Pediatr Transplant. 2026 Nov; 30(11).
-
Kawano K, Takahashi N, Kishimoto T, Kariu T, Fujiwara Y, Uemura M, Nakajima K, Kinjo N, Ueno-Shuto K, Nakashima R, Hayashi M, Suico MA, Shuto T. A gingipain-active extracellular protein/protease fraction from Porphyromonas gingivalis promotes epithelial CCL20 expression and ?d T-cell accumulation in COPD-like airways. J Pharmacol Sci. 2026 Dec; 162(4):346-359.
-
Kathania M, Raj D, Govindarajan T, Raju DR, Verma AK, Roy A, Mathur R, Woody J, Singh AK, Ahn C, Patel S, Yin J, Lemoff A, Theiss AL, Xing C, Wu T, Burstein E, Venuprasad K. Zbtb44-mediated transcriptional repression critically regulates colonic inflammation. Nat Immunol. 2026 Nov; 27(11):2215-2224.
-
Ang MJY, Luo Z, Mitchell MJ. The Modular CAR: Adapting T Cells without Reengineering Them. Cancer Immunol Res. 2026 Oct 05; 14(10):1536-1537.
-
Li L, Liu S, Lei Z, Macaluso J, Guo S, MacPhail K, Mroz MM, Restrepo CI, Yang IY, Maier LA. Immune regulation by CD55 in chronic beryllium disease. Am J Respir Cell Mol Biol. 2026 Oct 01; 74(10):1431-1439.
-
Pinto N, Künkele A, Albert CM, Taylor MR, Ullom HB, Vitanza NA, Wilson AL, Cole BL, Yeung CCS, Wright JH, Huang W, Wendler J, Seidel K, Brown C, Gustafson J, Rawlings-Rhea SD, Beebe A, Mgebroff S, Gardner RA, Jensen MC, Park JR. The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma. Clin Cancer Res. 2026 Sep 15; 32(18):4062-4074.
-
Hanna SJ, Robinson EJ, Thayer TC, Nakayama M, Landry L, Andrews R, Dolton G, Davies J, Williams E, Pearson JA, Sewell AK, Narendran P, Wraith DC, Howell A, Young P, Hart M, Lindqvist A, Wong FS, Tree TI, Dayan CM, Tatovic D. Tracking GAD-specific T cell expansions in type 1 diabetes by intradermal GAD-alum challenge. JCI Insight. 2026 Oct 22; 11(20).
-
Keller AL, Dennis KA, Ohlstrom DJ, Parzych SE, Walker ZJ, Novak AJ, Pham-Danis C, Medha TN, Rahkola JT, Boorgula MP, Kohler ME, Sherbenou DW. Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype. Cancer Immunol Res. 2026 Aug 04; 14(8):1307-1321.
-
Lin HK, Blake DA, Freeman R, Chen Y, Kim J, Johnson AM, Wells K, Mudigonda A, Liu W, Yadav P, Zeng F, Muhuri A, Min K, Sarkar S, Wang Y, Goyal S, Roberts RC, Christensen E, Ward AB, Heller B, Chun P, Dougan J, Porter CC, Barwick BG, Paulos CM, Yang L, Patgiri A, Thomas SN, Waller EK, Rafiq S. Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models. Sci Transl Med. 2026 Jul 22; 18(859):eadt9565.
-
Lindau PL, Nesta AV, Roe CE, Landis MD, Hatem Z, Sewell AE, Blount AK, Bader JE, Anupama R, Rathmell WK, Irish JM, Rathmell JC, Beckermann KE. Mitochondrial potential reflects T cell fitness and function during cancer immunotherapy. J Immunol. 2026 Jun 07; 215(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|